News

Credo's 20.3% monthly slide contrasts with triple-digit revenue growth, but premium valuation, customer concentration and execution risks remain.

Novo Nordisk has come under pressure after a prolonged slide in the share price, and the key issue now is whether the current valuation still lines up with what its earnings can reasonably support. With the stock well off its highs despite regular headlines about obesity drugs, AI partnerships and new therapies, investors are asking if the earnings story and the price tag still match. Over the past 3 years the share price has fallen 51.9%, which puts the spotlight squarely on whether the...

Energy Fuels and MP are expanding U.S. rare-earth supply chains, but differing strategies, costs and earnings trends shape the investment case.

Earlier this month, Critical Metals Corp. outlined detailed plans for its proposed CRML Romania mine-to-metals refinery, including process innovations aimed at maximizing value from the Tanbreez Rare Earth Project in Greenland and reducing tailings to about 1% of feed material. An interesting element of the announcement is the projected transformation of silica from a conventional waste stream into a high-purity product that current modelling suggests could generate very large annual revenue...

A major technology partner could accelerate Einride's biggest ambition

Bruker Corporation previously announced a multi-system order worth more than US$6.00 million from the University of California, Berkeley to equip the Pines Magnetic Resonance Center with next-generation high-field NMR instrumentation, including an AV NEO-X 800 MHz spectrometer with a cryogenically cooled MAS CryoProbe and multiple supporting systems, scheduled for delivery in 2027. This large academic investment highlights how Bruker’s advanced NMR platforms are being embedded in...

The cannabis stock has been struggling badly this year, but there could be a catalyst up ahead.

Clean Harbors stock jumps 10.4% in six months as expanding PFAS demand, stronger cash generation and a higher 2026 outlook fuel momentum.

When OpenAI agents attacked Hugging Face and rattled the AI sector, two tech giants barely flinched. Their secret sits inside the architecture powering their most ambitious bets on Siri, Robotaxi, and beyond.

Rachel Ruggeri, who had been the coffee shop giant’s CFO, was named a director at the fast-food burger chain.

One powerful macro force could overpower higher interest rates

WDC sees sovereign customers, neoclouds and physical AI broadening HDD demand, with tighter supply creating added pricing leverage.

Intuitive Surgical (ISRG) stock could climb 23.9% to the April high it last fell back from, and you would risk about 5% to find out. That looks like a surgical-robot leader on sale, but the price history disagrees. Over the last two years, none of its visits to this price range turned into a 20% gain before a 5% drop.

Apple's iPhone 18 Pro Is Seeing a Sharp Demand Surge, According to JPMorgan

These analysts have very different opinions on GE Vernova stock.

A far bigger test of tunnel economics is emerging

Clear Street said the U.S.-Greenland security deal could accelerate development of the company’s Tanbreez rare-earth project.

Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. Unfortunately, this role also comes with a demand profile tethered to the ebbs and flows of the broader economy, and the industry is currently lagging as its six-month return of 3.3% has trailed the S&P 500’s 16.4% gain.

Red Cat (NASDAQ:RCAT) is positioning its drone and unmanned surface vessel businesses around lessons drawn from active conflict zones, with Chairman and CEO Jeff Thompson emphasizing battlefield testing, production readiness and interoperability as key differentiators. Speaking at a Piper Sandler e

Key Takeaways; Psychedelic Sector Optimi Health Plans to Initiate Phase 3 Clinical Trial Evaluating MDMA Therapy for Individuals with PTSD Eli Lilly Completed $2.8 Billion Acquisition of AtaiBeckley, Expanding its Mental Health Pipeline Definium’s Phase 3 Panorama Trial Delivered Positive Results for DT120 in Generalized Anxiety Disorder Psyence BioMed Established Texas Entity to Advance U.S. […]

Sept 21 (Reuters) - Paramount Skydance has settled with California and 11 other states that sued to block its $110 billion acquisition of Warner Bros Discovery, a ‌source familiar with the matter said on Monday, clearing one of the last ‌hurdles to a deal that would reshape Hollywood. The settlement includes the creation of independent editorial boards for CNN and CBS, ​the source said, a move aimed at safeguarding the independence of their news operations under the combined company.

Super Micro just posted a quarter that sent analyst price targets soaring and earnings estimates jumping by 30% in a single month, yet the stock still trades below those targets and insiders are quietly selling. The setup looks compelling until you dig into what management said about where those profits actually came from.

Apple shares are trading near all-time highs with earnings momentum building fast, so a disciplined monthly stake through 2030 could look very different depending on which of three very specific scenarios plays out.

Meta keeps bleeding cash into AI infrastructure and Reality Labs while the market punishes every headline, yet one stubborn investor sees a reason to keep buying shares that most holders are dropping like they're on fire.

NBA star LeBron James will suit up for a new team in the 2026-27 season, joining the Philadelphia 76ers as the fourth team of his NBA career. James also has a new endorsement deal with Polymarket that will reward him...

Airbnb (ABNB) could add about 1 million rooms to its total addressable market by the end of the year

PM has raised its quarterly dividend by 8.8%, underscoring growth through smoke-free products, cost savings and strong brands.

The regulatory divide could reshape Big Tech's AI economics

NVO's Sogroya wins a positive CHMP opinion for idiopathic short stature in the EU, potentially broadening its pediatric growth disorder reach.

Two structural shifts could reshape how investors price risk